ArticleFrontiers in pharmacology2022

Wogonin increases gemcitabine sensitivity in pancreatic cancer by inhibiting Akt pathway.

Tianli Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.